Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000954836 | SCV001101500 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502967 | SCV002810265 | likely benign | Cerebellar atrophy, visual impairment, and psychomotor retardation; | 2021-09-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000954836 | SCV004123378 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | EMC1: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV000954836 | SCV005286051 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001700523 | SCV001921844 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700523 | SCV001970293 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004533678 | SCV004731691 | benign | EMC1-related disorder | 2019-11-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |